Respuesta tumoral a la quimioterapia neoadyuvante en subtipos moleculares de cáncer de mama en Medellín, Colombia. Estudio de cohorte retrospectivo [PDF]
Objetivos: describir la frecuencia de la respuesta clínica y patológica, entre los diferentes subtipos moleculares de cáncer de mama, en pacientes que previamente recibieron quimioterapia neoadyuvante.
Manuela Restrepo-Mejía +4 more
doaj +3 more sources
Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma [PDF]
Background Inflammation has an important role in cancer survival, yet whether serum markers of inflammation predict response to potentially curative neoadjuvant chemotherapy (NAC) in oesophageal adenocarcinoma (OAC) is controversial.
A. G. M. T. Powell +6 more
doaj +3 more sources
Respuesta patológica completa de pacientes con cáncer de mama HER2 positivo tratadas con quimioterapia neoadyuvante en Colombia [PDF]
Introduction. Breast cancer is the most common type of cancer and the leading cause of death by cancer in women in Colombia. Approximately 15 to 20% of breast cancers overexpress HER2. Objective.
Mauricio Rodríguez +4 more
doaj +2 more sources
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer. [PDF]
Deconditioning during neoadjuvant chemotherapy is a possible parameter for predicting operative outcomes. This retrospective cohort study aimed to assess body composition changes in patients with gastro‐oesophageal cancer during neoadjuvant therapy and investigate their association with postoperative complications. Skeletal muscle index values decrease
den Boer RB +9 more
europepmc +2 more sources
Dermatological Toxicity in Women With Breast Cancer Undergoing Chemotherapy Treatment Toxicidad dermatológica en mujeres con cáncer de mama sometidas a quimioterapia Toxicidade dermatológica em mulheres com câncer de mama submetidas à quimioterapia [PDF]
This study aimed to analyze the occurrence of skin toxicity caused by drugs used in the protocol of neoadjuvant and adjuvant chemotherapy among women with breast cancer.
Thais de Oliveira Gozzo +3 more
doaj +5 more sources
Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases. [PDF]
This study aimed to estimate the effect of neoadjuvant FOLFOX in patients undergoing upfront resectable colorectal liver metastases. After adjustment, no significant impact of FOLFOX was detected, suggesting that upfront surgery may be acceptable in patients with limited disease.
Allard MA +16 more
europepmc +2 more sources
Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy. [PDF]
Following propensity adjustment for stage, age and sex, neoadjuvant therapy was not associated with survival. Tumour regression is a powerful prognostic indicator, and future research should focus on identifying patients who will derive the most benefit from neoadjuvant chemotherapy.
Powell AGMT +5 more
europepmc +2 more sources
Multicentre study of prepectoral breast reconstruction using acellular dermal matrix. [PDF]
A UK multicentre audit of direct‐to‐implant prepectoral breast reconstructions using acellular dermal matrix was conducted for all patients operated on from January 2015 to December 2017 across 18 centres. In a median follow‐up of 9·7 months, the major complication rate was 15·3 per cent and the 90‐day implant removal rate 4·9 per cent.
Chandarana M +2 more
europepmc +2 more sources
Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus. [PDF]
A positive circumferential resection margin (CRM) has been shown to be an adverse prognostic indicator after oesophagectomy for adenocarcinoma. Clinical tumour status, tumour volume, poor differentiation, lack of response following chemotherapy and radiological assessment of invasion can be used to predict CRM positivity in oesophageal adenocarcinoma ...
Knight WRC +30 more
europepmc +2 more sources
Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado [PDF]
Introducción y objetivo: el abordaje de pacientes con cáncer epitelial de ovario (CEO) de alto grado avanzado o metastásico ha ido evolucionando a través del tiempo con el advenimiento de nuevas terapias y estrategias multimodales.
Marc E Pierre +11 more
doaj +2 more sources

